Novartis (NVS) Stock Statistics & Valuation Metrics

Novartis has a market cap or net worth of $197.70B. The enterprise value is $212.89B.

Novartis has 2.11B shares outstanding. The number of shares has decreased by -2.65% in one year.

Novartis’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 15.55%.

The current PE Ratio of Novartis is 16.29. Novartis’s PEG ratio is -0.99.

In the last 12 months, Novartis had revenue of $51.07B and earned $11.94B in profits. Earnings per share was $5.92.

In the last 12 months, operating cash flow was $17.62B and capital expenditures -$3.81B, giving a free cash flow of $13.80B billion.

Novartis pays an annual dividend of $2.52, resulting in a dividend yield of 3.17%

Novartis upcoming earnings date is Apr 29, 2025, TBA.

Novartis as a current ratio of 1.04, with Debt / Equity ratio of 0.71

In the past 12 months, Novartis has paid $1.70B in taxes.

Novartis EV to EBITDA ratio is 10.35, with an EV/FCF ratio of 15.53.

Novartis has $13.35B in cash and marketable securities with $31.26B in debt, giving a net cash position of $17.91B billion.

Gross margin is 75.20%, with operating margin of 28.12%, and net profit margin of 23.09%.

The average price target for Novartis is $111.00, which is 11.43% higher than the current price. The consensus rating is Hold